Adam Waldman gained a PhD and undertook post-doctoral research in biophysics before training in medicine at Cambridge. He trained in radiology at University College Hospitals and subsequently in neuroradiology at the National Hospital for neurology and Neurosurgery, Queen Square, London.
He has been Consultant Neuroradiologist at Imperial College Healthcare NHS Trust (formerly HHNT) since 2001. Since 2006 he has been departmental academic lead as Research Director for Radiology, and has developed a research management team that promotes and supports imaging in a wide range of research areas. He has also founded and leads an academic training programme in Clinical Radiology.
His main research interests are in quantitative and physiological neuroimaging, particularly as applied to neuro-oncology, neurodegenerative dementias and neuroinflammatory disease.
et al., 2021, Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort, Alzheimers & Dementia, Vol:17, ISSN:1552-5260, Pages:1189-1204
et al., 2021, A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research, Frontiers in Oncology, Vol:11, ISSN:2234-943X
et al., 2020, Identification of occult cerebral microbleeds in adults with immune thrombocytopenia, Blood, Vol:136, ISSN:0006-4971, Pages:2875-2880
et al., 2020, Chronic alcohol exposure differentially modulates structural and functional properties of amygdala: A cross-sectional study, Addiction Biology, Vol:26, ISSN:1355-6215
et al., 2020, Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol dependent individuals, Molecular Psychiatry, Vol:25, ISSN:1359-4184, Pages:1749-1758